Vaccine adjuvant discovery program

Awarded Award Notice Posted

Solicitation number
BAA-DAIT-75N93022R00022
Agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Awarded
to University Of Montana
Set-aside
No set-aside

Opportunity facts

Contract number
75N93024C00024 Federal contract award
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Place of performance
Missoula, Montana 59812, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a cost-reimbursement contract worth $10,172,188 to the University of Montana on September 19, 2024 for the Vaccine Adjuvant Discovery Program. The contract, which is not fixed-priced, was awarded under contract number 75N93024C00024 and involves the provision of goods and services related to vaccine adjuvant discovery.

Notice text

This is not fixed-priced. This is a cost-reimbursement contract.

Awarded contract 75N93024C00024 to UNIVERSITY OF MONTANA for 10172188.00 on 2024-09-19.

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Vaccine adjuvant discovery program This notice · Latest Award Notice
Vaccine adjuvant discovery program Award Notice
Vaccine adjuvant discovery program Award Notice
Vaccine adjuvant discovery program Award Notice
Vaccine adjuvant discovery program Latest solicitation Solicitation
Vaccine adjuvant discovery program Original Pre-Solicitation

And 1 more award notice.

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity